Contents14 – Compounded medication: what do we need to know? Rizvan Faruk Batha from Specialist Pharmacy tells Pharmafocus about the history and benefits of compounded medication and why it’s not as common in the UK as the rest of Europe, North America and Australia16 – Menopause legislation, charities and support Pharmafocus's Betsy Goodfellow explores the current menopause legislation and the calls for change, as well as considering the charities and support available17 – Menopause and sleep disruption Pharmafocus's Betsy Goodfellow evaluates the impact of menopause on sleep and the consequences this may haveTop News 5NICE approved BMS’s Opdivo for lung cancer
6Merck to appeal EU rejection of COVID-19 drug
7FDA sued by US states over abortion pill access
8Sun Pharma recalls at least 34,000 bottles of generic drug
9Wearable sensor helps detect heart attacks
12Sooma receives FDA Breakthrough Device designation for depression therapy device
Our TeamExecutive Director – PMGroup Worldwide Ltd
Karl Equi
Group Managing Editor
Iona Everson
ieverson@pmlive.comEditorial Assistants
Betsy Goodfellow
betsy@pharmafile.com
James Spargo
james@samedanltd.com
Sales Manager
Eliot Haynes
eliot@pharmafile.comDesign & Layout
Peter May
designer@samedanltd.com
Pharmafocus is published by:Samedan Ltd
Suite E, 11 Bell Yard Mews,
175 Bermondsey Street,
London, SE1 3TN
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
www.pharmafile.comSubscriptions & Data ManagementCurwood CMS Tel: 01580 883840enquiries@c-cms.comISSN: 1465-5403
Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.©2022 Samedan Ltd, Pharmaceutical PublishersThe opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.